Impact of GLP-1 and dual agonists on the incidence of new cases of physician-reported sleep apnea: a real-world study
{{output}}
Rationale: Previous studies have shown that glucagon-like peptide-1 (GLP-1) agonists and dual GLP-1/glucose-dependent insulinotropic peptide (GIP) agonists (tirzepatide) reduced severity of sleep apnea. However, whether these med... ...
